China
· Delayed Price · Currency is CNY China Resources Boya Bio-pharmaceutical Group Co.,Ltd Statistics
Total Valuation
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has a market cap or net worth of CNY 16.71 billion. The enterprise value is 11.24 billion.
| Market Cap | 16.71B |
| Enterprise Value | 11.24B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Apr 26, 2024 |
Share Statistics
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has 504.25 million shares outstanding. The number of shares has increased by 1.11% in one year.
| Shares Outstanding | 504.25M |
| Shares Change (YoY) | +1.11% |
| Shares Change (QoQ) | -2.06% |
| Owned by Insiders (%) | 4.44% |
| Owned by Institutions (%) | 17.37% |
| Float | 277.19M |
Valuation Ratios
The trailing PE ratio is 73.60 and the forward PE ratio is 28.45. China Resources Boya Bio-pharmaceutical Group Co.,Ltd's PEG ratio is 0.42.
| PE Ratio | 73.60 |
| Forward PE | 28.45 |
| PS Ratio | 8.34 |
| PB Ratio | 2.23 |
| P/FCF Ratio | 44.42 |
| PEG Ratio | 0.42 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 18.88, with an EV/FCF ratio of 29.89.
| EV / Earnings | 49.42 |
| EV / Sales | 5.60 |
| EV / EBITDA | 18.88 |
| EV / EBIT | 22.27 |
| EV / FCF | 29.89 |
Financial Position
The company has a current ratio of 13.08, with a Debt / Equity ratio of 0.00.
| Current Ratio | 13.08 |
| Quick Ratio | 11.94 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.05 |
| Debt / FCF | 0.07 |
| Interest Coverage | 1,813.11 |
Financial Efficiency
Return on equity (ROE) is 3.09% and return on invested capital (ROIC) is 4.20%.
| Return on Equity (ROE) | 3.09% |
| Return on Assets (ROA) | 3.90% |
| Return on Capital (ROIC) | 4.20% |
| Revenue Per Employee | 1.39M |
| Profits Per Employee | 157,561 |
| Employee Count | 1,444 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.97% in the last 52 weeks. The beta is 0.38, so China Resources Boya Bio-pharmaceutical Group Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.38 |
| 52-Week Price Change | +11.97% |
| 50-Day Moving Average | 32.38 |
| 200-Day Moving Average | 31.57 |
| Relative Strength Index (RSI) | 50.09 |
| Average Volume (20 Days) | 8,406,497 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, China Resources Boya Bio-pharmaceutical Group Co.,Ltd had revenue of CNY 2.01 billion and earned 227.52 million in profits. Earnings per share was 0.45.
| Revenue | 2.01B |
| Gross Profit | 1.22B |
| Operating Income | 504.86M |
| Pretax Income | 327.97M |
| Net Income | 227.52M |
| EBITDA | 592.88M |
| EBIT | 504.86M |
| Earnings Per Share (EPS) | 0.45 |
Balance Sheet
The company has 5.49 billion in cash and 26.86 million in debt, giving a net cash position of 5.47 billion or 10.84 per share.
| Cash & Cash Equivalents | 5.49B |
| Total Debt | 26.86M |
| Net Cash | 5.47B |
| Net Cash Per Share | 10.84 |
| Equity (Book Value) | 7.49B |
| Book Value Per Share | 14.84 |
| Working Capital | 6.14B |
Cash Flow
In the last 12 months, operating cash flow was 460.20 million and capital expenditures -83.98 million, giving a free cash flow of 376.22 million.
| Operating Cash Flow | 460.20M |
| Capital Expenditures | -83.98M |
| Free Cash Flow | 376.22M |
| FCF Per Share | 0.75 |
Margins
Gross margin is 61.01%, with operating and profit margins of 25.16% and 11.34%.
| Gross Margin | 61.01% |
| Operating Margin | 25.16% |
| Pretax Margin | 16.34% |
| Profit Margin | 11.34% |
| EBITDA Margin | 29.54% |
| EBIT Margin | 25.16% |
| FCF Margin | 18.75% |
Dividends & Yields
This stock pays an annual dividend of 0.32, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | 0.32 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | 50.00% |
| Years of Dividend Growth | 2 |
| Payout Ratio | 81.46% |
| Buyback Yield | -1.11% |
| Shareholder Yield | -0.19% |
| Earnings Yield | 1.36% |
| FCF Yield | 2.25% |
Stock Splits
The last stock split was on May 26, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 26, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
China Resources Boya Bio-pharmaceutical Group Co.,Ltd has an Altman Z-Score of 19.51.
| Altman Z-Score | 19.51 |
| Piotroski F-Score | n/a |